MELTZ MARK A (COO General Counsel Treasurer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/5/2024ACC: 0001415889-24-006753
Officer· COO General Counsel Treasurer
Since Dec 2020
-558.00
Net shares
Net seller
$1.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
558.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−558.00
Price / share
$2.59
Trade value
$1.45K
% of position
2.0%
3/1/2024
28.14K→27.58K
Total
Net shares
−558.00
Net value
-$1.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −558.00 | $2.59 | $1.45K | 2.0% | 28.14K | 27.58K |
| Total | −558.00 | -$1.45K | ||||||
Derivative Transactions0
No derivative transactions reported